
Sign up to save your podcasts
Or


Credits: 0.25 AMA PRA Category 1 Credit™
Overview: Many patients with chronic obstructive pulmonary disease (COPD) are improperly treated with inhaled corticosteroids (ICS), increasing their risk of harm. This episode explores the latest evidence on long-term ICS risks and provides practical guidance to help you align COPD care with current guidelines—improving outcomes while minimizing adverse effects like pneumonia, cataracts, type 2 diabetes mellitus, and osteoporosis.
Episode resource links:
Guest: Jillian Joseph, PA-C
Thoughts? Suggestions? Email us at [email protected]
By Pri-Med4.5
8585 ratings
Credits: 0.25 AMA PRA Category 1 Credit™
Overview: Many patients with chronic obstructive pulmonary disease (COPD) are improperly treated with inhaled corticosteroids (ICS), increasing their risk of harm. This episode explores the latest evidence on long-term ICS risks and provides practical guidance to help you align COPD care with current guidelines—improving outcomes while minimizing adverse effects like pneumonia, cataracts, type 2 diabetes mellitus, and osteoporosis.
Episode resource links:
Guest: Jillian Joseph, PA-C
Thoughts? Suggestions? Email us at [email protected]

136 Listeners

699 Listeners

496 Listeners

256 Listeners

295 Listeners

263 Listeners

3,339 Listeners

1,151 Listeners

194 Listeners

92 Listeners

512 Listeners

366 Listeners

247 Listeners

373 Listeners

314 Listeners